UnlikeASXL1andASXL2mutations,ASXL3mutations are rare events in acute myeloid leukemia with t(8;21)
- 15 May 2015
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 57 (1) , 199-200
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- ASXL genes and RUNX1: an intimate connection?Blood, 2014
- Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocationsBlood, 2014
- High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcomeLeukemia, 2014
- Functional and cancer genomics of ASXL family membersBritish Journal of Cancer, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndromeGenome Medicine, 2013
- The ASXL–BAP1 axis: new factors in myelopoiesis, cancer and epigeneticsLeukemia, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseasesJournal of Hematology & Oncology, 2012
- Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemiaBritish Journal of Haematology, 2009